Exact Mass: 509.38450460000007
Exact Mass Matches: 509.38450460000007
Found 27 metabolites which its exact mass value is equals to given mass value 509.38450460000007,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
LysoPC(O-18:0)
1-Octadecyl-sn-glycero-3-phosphocholine is an intermediate in the ether lipid metabolism pathway. 1-Octadecyl-sn-glycero-3-phosphocholine is irreversibly produced from 2-acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine via the enzyme 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47). 1-Octadecyl-sn-glycero-3-phosphocholine is an ether phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol are bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. 1-Octadecyl-sn-glycero-3-phosphocholine is an intermediate in the ether lipid metabolism pathway. 1-Octadecyl-sn-glycero-3-phosphocholine is irreversibly produced from 2-acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine via the enzyme 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47). 1-Octadecyl-sn-glycero-3-phosphocholine is an ether phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol are bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.
Phosphatidylcholine lyso alkyl 18:0
C26H56NO6P (509.38450460000007)
cyclo (-Gly-L-Orn-L-Val-3-amino-12-methyltetradecanoyl-)|rhodopeptin C4
C27H51N5O4 (509.39408460000004)
2-O-ethyl PAF C-16
C26H56NO6P (509.38450460000007)
PC(O-10:0/O-8:0)[U]
C26H56NO6P (509.38450460000007)
PC(O-16:0/O-2:0)
C26H56NO6P (509.38450460000007)
PC(O-16:0/O-2:0)[U]
C26H56NO6P (509.38450460000007)
PC(O-17:0/O-1:0)[U]
C26H56NO6P (509.38450460000007)
PC(O-2:0/O-16:0)[U]
C26H56NO6P (509.38450460000007)
PC(O-9:0/O-9:0)[U]
C26H56NO6P (509.38450460000007)
Ro 14-8160
C26H56NO6P (509.38450460000007)
PC(O-18:0/0:0)[S]
C26H56NO6P (509.38450460000007)
Ro 14-0859
C26H56NO6P (509.38450460000007)
1-O-Hexadecyl-2-O-ethyl-SN-glycero-3-phosphorylcholine
C26H56NO6P (509.38450460000007)
(3-Hydroxy-2-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C26H56NO6P (509.38450460000007)
1-O-Hexadecyl-2-O-ethyl-sn-glycero-3-phosphocholine
C26H56NO6P (509.38450460000007)
2-Aminoethyl (3-henicosoxy-2-hydroxypropyl) hydrogen phosphate
C26H56NO6P (509.38450460000007)
(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]octadeca-3,6,9,12,15-pentaenamide
C33H51NO3 (509.38687360000006)
1-octadecylglycero-3-phosphocholine
C26H56NO6P (509.38450460000007)
A 1-alkylglycero-3-phosphocholine in which the alkyl group is specified as octadecyl.
(2-{[(2r)-2-hydroxy-3-(octadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
C26H56NO6P (509.38450460000007)
6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol
C27H51N5O4 (509.39408460000004)
(3s,6s,13r)-6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol
C27H51N5O4 (509.39408460000004)
(3s,6s)-6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol
C27H51N5O4 (509.39408460000004)
(3s,6s,9r)-13-heptyl-5,8,11-trihydroxy-3,6,9-tris(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one
C28H51N3O5 (509.38285160000004)